Status
Conditions
Treatments
About
The randomized, placebo-controlled multicenter trial is conducted in three centers in China. After screening and obtaining the signed informed consent, the participants are randomly divided into two groups: acupuncture group and sham acupuncture group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients who met any of the following conditions were not included:
Primary purpose
Allocation
Interventional model
Masking
180 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Cuihong Zheng, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal